Skip to main content
Livermore
Livermore
ZHEN

Morgan Stanley

SEC CIK
0000895421
Latest filing
Aug 13, 2026

CLRB holding history

Cellectar Biosciences, Inc. in every 13F filed by Morgan Stanley, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

CLRB overviewAll 13F holders of CLRBFull Q2 2026 holdings

Shares (Q2 2026)
510
Value
$1.42K
% of portfolio
<0.1%
Quarters held
22
Since Q1 2021
Holdings of CLRB by Morgan Stanley, by quarter
QuarterSharesValue% of portfolioShare changeActionAll holders
Q2 2026510$1.42K<0.1%00.0%UnchangedHolders
Q1 2026510$1.29K<0.1%00.0%UnchangedHolders
Q4 2025510$1.50K<0.1%00.0%UnchangedHolders
Q3 2025510$2.86K<0.1%00.0%UnchangedHolders
Q2 2025510$3.63K<0.1%−14,795−96.7%ReducedHolders
Q1 202515,305$4.83K<0.1%−163,414−91.4%ReducedHolders
Q4 2024178,719$53.4K<0.1%+39,488+28.4%AddedHolders
Q3 2024139,231$298.0K<0.1%+55,789+66.9%AddedHolders
Q2 202483,442$208.6K<0.1%+62,191+292.6%AddedHolders
Q1 202421,251$84.6K<0.1%+6,195+41.1%AddedHolders
Q4 202315,056$41.7K<0.1%+56+0.4%AddedHolders
Q3 202315,000$39.6K<0.1%00.0%UnchangedHolders
Q2 202315,000$29.3K<0.1%00.0%UnchangedHolders
Q1 202315,000$21.4K<0.1%00.0%UnchangedHolders
Q4 202215,000$25.6K<0.1%−10.0%ReducedHolders
Q3 202215,001$50.0K<0.1%+14,999+789,426.3%AddedConverted for a 1-for-10 splitHolders
Q2 202219$00.0%−3−13.6%ReducedHolders
Q1 202222$00.0%−276,954−100.0%ReducedHolders
Q4 2021276,976$184.0K<0.1%−301,385−52.1%ReducedHolders
Q3 2021578,361$535.0K<0.1%+448,758+346.3%AddedHolders
Q2 2021129,603$155.0K<0.1%+127,384+5,740.6%AddedHolders
Q1 20212,219$4.00K<0.1%––Holders

Livermore's 13F data starts with Q1 2021, so Q1 2021 has no change from the previous quarter.